Humalog

Humalog

insulin lispro

Manufacturer:

Eli Lilly

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Insulin lispro (recombinant DNA origin)
Indications/Uses
Adults & childn w/ DM for maintenance of normal glucose homeostasis. Initial stabilisation of DM.
Dosage/Direction for Use
Administration
Should be taken with food: Administer w/in 15 min before or immediately after meals.
Contraindications
Special Precautions
Transferring from other insulins. Illness or emotional disturbances. Hyper-/hypoglycemia. Increased physical activity or diet changes. Combination w/ thiazolidinediones. May affect ability to drive & use machines. Renal or hepatic impairment. Pregnancy & lactation.
Adverse Reactions
Hypoglycemia. Local allergy eg, inj site redness, swelling & itching.
Drug Interactions
Increased insulin requirements by OCs, corticosteroids or thyroid replacement therapy, danazol, β2-stimulants. Decreased insulin requirements w/ oral hypoglycaemics, salicylates, sulpha antibiotics, MAOIs, SSRIs, ACE inhibitors, angiotensin II receptor blockers, β-blockers, octreotide or alcohol.
MIMS Class
Insulin Preparations
ATC Classification
A10AB04 - insulin lispro ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Humalog KwikPen inj 100 IU/mL
Packing/Price
3 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in